Arista Networks forecast second-quarter revenue above Wall Street estimates following upbeat first-quarter results on Tuesday, betting on growing demand for its networking equipments amid the ...

Astera Labs reports Q1 2025 revenue of $159.4 million, driven by strong PCIe and Ethernet solution demand. Astera Labs, Inc. reported record revenue of $159.4 million for the first quarter of ...

Onsemi forecast second-quarter revenue above Wall Street expectations on Monday, as demand for its chips used in electric vehicles remains resilient despite economic uncertainty brought on by U.S ...

New Delhi: India’s cotton yarn industry is poised for a stronger performance this fiscal, with revenue expected to ... improving export demand—particularly from China—and stable cotton ...

Still, the smartphone market - the company's biggest revenue segment - is facing pressure, with estimates pointing to a decline in smartphone demand this year. Policy uncertainty is also clouding ...

(Reuters) - Palantir Technologies raised its annual sales forecast on Monday, although its inline profit and a modest revenue beat disappointed investors who were expecting more from the AI-focused ...

For fiscal year 2025, the Denver, Colorado-based company now expects revenue in between $3.89 billion and $3.90 billion, up from its earlier forecast of sales between $3.74 billion and $3.76 billion.

BioNTech SE fell as much as 4.2% after the German drugmaker posted lower-than-expected quarterly sales on weaker demand for its Covid-19 vaccine. First-quarter revenue declined to €182.8 million ($207 ...

“AI is enabling entirely new business models from on-demand, consumption-based and outcome-driven, that create massive complexity in how companies recognize revenue,” said founder and Chief ...

Despite the revenue challenges, the company managed to improve its gross ... ongoing challenges in the global business environment. The company noted that demand was impacted by weak consumer and ...

Eli Lilly LLY2.48%increase; green up pointing triangle revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged net ...